These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23233321)

  • 1. von Willebrand factor inhibition improves endothelial function in patients with stable angina.
    Muller O; Bartunek J; Hamilos M; Berza CT; Mangiacapra F; Ntalianis A; Vercruysse K; Duby C; Wijns W; De Bruyne B; Heyndrickx GR; Vanderheyden M; Holz JB; Barbato E
    J Cardiovasc Transl Res; 2013 Jun; 6(3):364-70. PubMed ID: 23233321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antiplatelet agents: ALX-0081, a Nanobody directed towards von Willebrand factor.
    Bartunek J; Barbato E; Heyndrickx G; Vanderheyden M; Wijns W; Holz JB
    J Cardiovasc Transl Res; 2013 Jun; 6(3):355-63. PubMed ID: 23307200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial.
    Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
    Atherosclerosis; 2015 Jun; 240(2):351-4. PubMed ID: 25875387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.
    van Loon JE; de Jaegere PP; Ulrichts H; van Vliet HH; de Maat MP; de Groot PG; Simoons ML; Leebeek FW
    Thromb Haemost; 2011 Jul; 106(1):165-71. PubMed ID: 21655675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel.
    Hamilos M; Muller O; Ntalianis A; Trana C; Bartunek J; Sarno G; Mangiacapra F; Dierickx K; Meeus P; Cuisset T; De Bruyne B; Wijns W; Barbato E
    J Thromb Thrombolysis; 2011 Jul; 32(1):64-71. PubMed ID: 21290254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
    Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
    Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Siller-Matula J; Lang IM; Schoergenhofer C; Roest M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1730-1738. PubMed ID: 28726980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.
    Jin H; Chen Y; Wang B; Zhu Y; Chen L; Han X; Ma G; Liu N
    BMC Cardiovasc Disord; 2018 Feb; 18(1):23. PubMed ID: 29409455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
    Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.
    Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
    J Cardiovasc Transl Res; 2014 Mar; 7(2):226-31. PubMed ID: 24142804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
    Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
    Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
    Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
    J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting von Willebrand factor and platelet glycoprotein Ib receptor.
    Firbas C; Siller-Matula JM; Jilma B
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1689-701. PubMed ID: 21108551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function.
    Di Serafino L; Pyxaras SA; Mangiacapra F; Dierickx K; Toth G; Bartunek J; De Bruyne B; Van Mieghem C; Wijns W; Barbato E
    EuroIntervention; 2013 Mar; 8(11):1252-8. PubMed ID: 23538154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
    Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].
    Chen ZQ; Hong L; Wang H; Yin QL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):415-20. PubMed ID: 27323611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor is present in the vascular endothelium from normal dogs and from Doberman pinscher dogs with a plasma von Willebrand factor deficiency.
    Meyers KM; Wardrop KJ; Helmick C; White F
    Thromb Res; 1990 Jan; 57(1):109-16. PubMed ID: 2405539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tetramethylpyrazine on platelet activation and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention].
    Chen ZQ; Hong L; Wang H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1078-81. PubMed ID: 18198639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.